ARRAY BIOPHARMA INC. news, videos and press releases
For more news please use our advanced search feature.
ARRAY BIOPHARMA INC. - More news...
ARRAY BIOPHARMA INC. - More news...
-
Array BioPharma Inc. - ARRY Stock Chart Technical Analysis for 10-15-2020
- Array BioPharma Announces Interim Analysis Results from the BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer
- Array BioPharma to Present Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E- Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer
- URGENT ALERT: Monteverde & Associates PC Launches an Investigation Regarding the Following Merger
- SHAREHOLDER ALERT: WeissLaw LLP Investigates Array BioPharma Acquisition
- Thinking about buying stock in Aurora Cannabis, Array Biopharma, Beyond Meat, Dare Bioscience, or Uniqure?
- Array BioPharma to Present at the Goldman Sachs 40ᵗʰ Annual Global Healthcare Conference
- Array BioPharma to Present at the Jefferies 2019 Global Healthcare Conference
- Array BioPharma Announces Presentation of Updated Overall Survival from the Phase 3 COLUMBUS Trial of BRAFTOVI + MEKTOVI in advanced BRAF-mutant Melanoma at 2019 ASCO Annual Meeting
- Array BioPharma Announces BRAFTOVI + MEKTOVI + Cetuximab Meet Primary Endpoints of ORR and OS in Phase 3 BEACON CRC Trial Interim Analysis for the Treatment of BRAF(V600E)-mutant Metastatic Colorectal Cancer
- Array BioPharma to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference
- Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2019
- Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2019 on May 7, 2019
- Array BioPharma to Present at the 39th Annual Cowen Health Care Conference
- Array BioPharma to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
- Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2019
- Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2019 on February 5, 2019
- Array BioPharma Announces 15.3 Months Median Overall Survival from the Safety Lead-in of the Phase 3 BEACON CRC Trial of the Combination BRAFTOVI®, MEKTOVI® and ERBITUX® in BRAF-Mutant Metastatic Colorectal Cancer
- Array BioPharma to Present at the 37th Annual J.P. Morgan Healthcare Conference
- Array BioPharma to Present at the 30th Annual Piper Jaffray Healthcare Conference
- Array BioPharma to Present at the Stifel 2018 Healthcare Conference and the Jefferies 2018 London Healthcare Conference
- Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2019
- Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2019 on October 30, 2018
- Array BioPharma to Present at the 2018 Cantor Global Healthcare Conference
- European Commission Approves BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) for Advanced BRAF-mutant Melanoma
- Array BioPharma Announces Publication of BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) Phase 3 Overall Survival Data in The Lancet Oncology
- Array BioPharma to Present at the Wells Fargo Securities 2018 Healthcare Conference
- Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018
- Array BioPharma Names Carrie S. Cox Chairman of its Board of Directors
- Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2018 on August 14, 2018
